AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 104 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,433,440 | -18.1% | 235,836 | -10.1% | 0.02% | -10.7% |
| Q1 2024 | $11,521,984 | +19427.1% | 262,400 | +20352.1% | 0.03% | – |
| Q3 2023 | $59,005 | -97.6% | 1,283 | -98.0% | 0.00% | -100.0% |
| Q1 2023 | $2,453,168 | -28.4% | 65,418 | -59.7% | 0.01% | -55.6% |
| Q2 2019 | $3,426,000 | +181.1% | 162,286 | +149.7% | 0.02% | +260.0% |
| Q1 2018 | $1,219,000 | -33.2% | 65,000 | -31.4% | 0.01% | -37.5% |
| Q4 2017 | $1,824,000 | -41.7% | 94,820 | -45.8% | 0.01% | -55.6% |
| Q2 2017 | $3,126,000 | – | 175,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Summit Global Investments | 58,640 | $870,000 | 0.13% |
| FEDERATED HERMES, INC. | 2,600,120 | $38,586,000 | 0.11% |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. | 284,328 | $4,219,000 | 0.07% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 291,352 | $4,324,000 | 0.05% |
| MARSHALL WACE, LLP | 301,910 | $4,481,000 | 0.04% |
| MARTINGALE ASSET MANAGEMENT L P | 212,817 | $3,159,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 171,266 | $2,542,000 | 0.03% |
| WINTON GROUP Ltd | 82,402 | $1,223,000 | 0.03% |
| EAGLE ASSET MANAGEMENT INC | 317,988 | $4,718,000 | 0.03% |
| Engineers Gate Manager LP | 24,007 | $356,000 | 0.03% |